Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares 1 3 Year Treasury Bond ETF (SHY) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance

iShares 1 3 Year Treasury Bond ETFTrade
SELLAS Life Sciences Group Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares 1 3 Year Treasury Bond ETF vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? iShares 1 3 Year Treasury Bond ETF trades at $81.22 (market cap $26.68B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B). The key difference: iShares 1 3 Year Treasury Bond ETF is far larger — about 11.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

SHYSLS
Market Cap
$26.68B$2.27B
Volume
4,077,6914,179,659
Sector
Fixed IncomeHealth
52-Week High
$83.18$15.46
52-Week Low
$81.05$1.39
Typical Hold Time
63 Days—
Enterprise Value
—$2.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares 1 3 Year Treasury Bond ETF

SHY is trading at $81.16 with minimal daily movement (+0.04%), showing stability amid broader bond market volatility. The technical picture remains bearish with moving averages signaling downward pressure, while oscillators suggest neutral momentum. Recent corporate actions include consistent dividend payments, with the latest being $0.24 per share. The fund operates in a challenging interest rate environment where short-term bond ETFs face both opportunities and headwinds from Federal Reserve policy shifts.

The outlook for SHY is mixed, with potential benefits from rising short-term yields but significant pressure from the ongoing bond market selloff. Investment opportunities include exposure to increasing interest rates with limited duration risk, while risks encompass continued bond market volatility and macroeconomic uncertainty driving yields higher. The fund's stability and dividend consistency provide some defensive characteristics in turbulent markets.

SELLAS Life Sciences Group Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SHY
100% Buy0% Sell
Avg holding period · 63 Days
SLS

No sentiment data available yet.

About iShares 1 3 Year Treasury Bond ETF

SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.

Read more on SHY →

About SELLAS Life Sciences Group Inc. Common Stock

SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.

Read more on SLS →